
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money has been increasing their position in the stock.
Growth: Good revenue growth. With 51.2% growth over past three years, the company is going strong.
Technicals: Bullish SharesGuru indicator.
Momentum: Stock is suffering a negative price momentum. Stock is down -4.5% in last 30 days.
Size: It is a small market cap company and can be volatile.
Balance Sheet: Caution! Weak Balance sheet.
Past Returns: Underperforming stock! In past three years, the stock has provided -1.2% return compared to 6.9% by NIFTY 50.
Valuation | |
|---|---|
| Market Cap | 818.78 Cr |
| Price/Earnings (Trailing) | 29.59 |
| Price/Sales (Trailing) | 1.87 |
| EV/EBITDA | 9.25 |
| Price/Free Cashflow | 9.95 |
| MarketCap/EBT | 25.62 |
| Enterprise Value | 902.67 Cr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 438.34 Cr |
| Rev. Growth (Yr) | 38.5% |
| Earnings (TTM) | 28.93 Cr |
| Earnings Growth (Yr) | -39.3% |
Profitability | |
|---|---|
| Operating Margin | 7% |
| EBT Margin | 7% |
| Return on Equity | 10.5% |
| Return on Assets | 0.00% |
| Free Cashflow Yield | 10.05% |
Growth & Returns | |
|---|---|
| Price Change 1W | -1.3% |
| Price Change 1M | -4.5% |
| Price Change 6M | -11.8% |
| Price Change 1Y | -45.8% |
| 3Y Cumulative Return | -1.2% |
| 5Y Cumulative Return | 32.3% |
| 7Y Cumulative Return | 23.2% |
| 10Y Cumulative Return | 16.1% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -38.67 Cr |
| Cash Flow from Operations (TTM) | 82.26 Cr |
| Cash Flow from Financing (TTM) | -56.17 Cr |
| Cash & Equivalents | 14.1 Cr |
| Free Cash Flow (TTM) | 82.26 Cr |
| Free Cash Flow/Share (TTM) | 30 |
Balance Sheet | |
|---|---|
| Total Assets | 0.00 |
| Total Liabilities | 766.1 Cr |
| Shareholder Equity | 275.55 Cr |
| Current Assets | 155.04 Cr |
| Current Liabilities | 146.34 Cr |
| Net PPE | 158.9 Cr |
| Inventory | 3.04 Cr |
| Goodwill | 17.64 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.36 |
| Interest Coverage | -0.09 |
| Interest/Cashflow Ops | 3.35 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 2.5 |
| Dividend Yield | 0.84% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money has been increasing their position in the stock.
Growth: Good revenue growth. With 51.2% growth over past three years, the company is going strong.
Technicals: Bullish SharesGuru indicator.
Momentum: Stock is suffering a negative price momentum. Stock is down -4.5% in last 30 days.
Size: It is a small market cap company and can be volatile.
Balance Sheet: Caution! Weak Balance sheet.
Past Returns: Underperforming stock! In past three years, the stock has provided -1.2% return compared to 6.9% by NIFTY 50.
Investor Care | |
|---|---|
| Dividend Yield | 0.84% |
| Dividend/Share (TTM) | 2.5 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 10.09 |
Financial Health | |
|---|---|
| Current Ratio | 1.06 |
| Debt/Equity | 0.36 |
Technical Indicators | |
|---|---|
| RSI (14d) | 34.14 |
| RSI (5d) | 29.79 |
| RSI (21d) | 40.28 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Buy |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Buy |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of Royal Orchid Hotels's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
In the earnings conference call for the fourth quarter and year ended March 31, 2026, management provided an optimistic outlook, emphasizing growth and operational efficiencies. For FY26, consolidated revenue from operations increased to INR 384 crores from INR 319 crores in the previous year, with EBITDA standing at INR 110 crores, and a profit after tax of INR 33 crores. The earnings per share reported was INR 11.74, showcasing the robust performance of the business model.
Management outlined key forward-looking points, including:
The management's confidence stems from structured growth strategies and a commitment to operational excellence amidst a dynamic market environment, indicating a positive trajectory for the coming years.
Question by Sucrit Patil: What type of strategic levers is Royal Orchid prioritizing in FY26-'27 to expand its portfolio beyond 120 hotels, while managing risk from regulatory changes, rising costs, and competitive pressures?
Answer: We are focusing on our upcoming hotel pipeline, with 52 signed hotels comprising 3,600 rooms. Our development team is actively scouting for properties. The market dynamics have strengthened our brand awareness and reach, allowing us to continue our growth on an asset-light strategy, balancing managed, franchised, and flexible lease properties.
Question by Sucrit Patil: What type of financial frameworks are being applied in FY2027 to align debt majorities and refinancing schedules with project cash flows?
Answer: Our consolidated balance sheet shows cash equivalents of around INR100 crores. Our borrowings total INR91 crores. This level of cash allows us to focus on growth without immediately needing to become debt-free. We will continue to leverage this for further expansion through management contracts and flexi-leases.
Question by Bharat Gianani: What was the impact of the West Asia crisis in Q4, particularly for ICONIQA Mumbai, and what is the medium-term revenue and EBITDA guidance for FY27-'28?
Answer: The geopolitical crisis indeed impacted us, especially with cancellations in March following the war, affecting ADR and occupancy. Looking ahead, we currently cannot provide specific guidance due to ongoing uncertainties, but we are committed to improving performance as the geopolitical landscape stabilizes.
Question by Chirag Singhal: Can you clarify the INR5.5 crore write-off regarding pre-operating expenses in ICONIQA, and what was the occupancy for the hotel in Q4?
Answer: The INR5.5 crore write-off was identified during the audit as not qualifying for capitalization. Regarding occupancy, ICONIQA achieved 62% in Q4, with January at 80% and February at 73%. The cancellations in March significantly impacted our performance.
Question by Udit Sehgal: When can we expect to see actual improvements in cash and PAT levels from hotel expansions?
Answer: While we have strong cash levels at around INR602 crores, the first year of ICONIQA has affected our PAT due to notional costs. With current growth patterns, I expect to see improvements, but reliability in predictions is difficult until we clear the first quarter of FY27.
Question by Anubhav Jain: When do you expect ICONIQA Mumbai to be profitable at the PAT level, and is room rate growth derived from better pricing or premium hotels?
Answer: We anticipate ICONIQA to achieve PAT profitability in FY27, but it may still be negative for FY26 due to Ind AS effects. Our room rate growth is a result of increased pricing and the addition of premium hotels to our portfolio.
Question by Bharat Gianani: Out of the 52 pipeline hotels, what approximate key count will be revenue share properties?
Answer: Approximately 522 keys will come from revenue share projects, expected to launch within this year, although precise timelines can be unpredictable due to external factors like construction delays.
This summary captures critical questions and answers from the Q&A section during the earnings conference call, focusing on strategic growth, financial performance, hotel operations, and market conditions.
Understand Royal Orchid Hotels ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Chander Kamal Baljee | 38.95% |
| BALJEES HOTELS AND REAL ESTATE P LTD | 20.84% |
| FIRST WATER FUND | 3.69% |
| JUPITER INDIA FUND | 3.05% |
| HARSHA FARMS PRIVATE LIMITED | 1.78% |
| Sunita Baljee | 1.6% |
| THE JUPITER GLOBAL FUND - JUPITER INDIA SELECT | 1.3% |
| VAIBHAV DOSHI | 1.1% |
| HOTEL STAY LONGER PVT LTD | 0.84% |
| SUNIL SIKKA | 0.05% |
| KESHAV BALJEE | 0% |
| ARJUN BALJEE | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Royal Orchid Hotels against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| INDHOTEL | Indian Hotels Co. | 1.02 LCr | 10.29 kCr | -2.80% | -7.10% | 47.78 | 9.96 | - | - |
| CHALET | Chalet Hotels | 19.64 kCr | 2.43 kCr | +6.80% | -11.70% | 37.16 | 8.1 | - | - |
| EIHOTEL | EIH | 18.25 kCr | 3.19 kCr | -11.00% | -29.20% | 25.65 | 5.71 | - | - |
| LEMONTREE | Lemon Tree Hotels | 8.31 kCr | 1.48 kCr | -6.90% | -38.60% | 35.34 | 5.61 | - | - |
| ASIANHOTNR | Asian Hotels (North) | 1.64 kCr | 356.7 Cr | +25.50% | +15.90% | -7.15 | 4.6 | - | - |
Royal Orchid Hotels Limited, together with its subsidiaries, operates and manages hotels and resorts for business and leisure travelers in India, Nepal, Sri Lanka, and Tanzania. The company operates 5-star and 4-star hotels and resorts under the Regenta, Regenta Central, Regenta Resort, Regenta Place, and Regenta Inn brands. It also offers restaurant services. The company was formerly known as Universal Resorts Limited and changed its name to Royal Orchid Hotels Limited in 1997. Royal Orchid Hotels Limited was incorporated in 1986 and is headquartered in Bengaluru, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.